Catalyst
Slingshot members are tracking this event:
AstraZeneca to Conduct Phase 2a Clinical Study of AZD1419 in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 20, 2016
Occurred Source:
https://clinicaltrials.gov/archive/NCT02898662/2016_10_20/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Immuno-oncology, Asthma, Phase 2a, Azd1419
